An interventional study of Video-conferencing group in Breastfeeding, Anxiety Disorders and Neonatal Outcomes, sponsored by Kahramanmaras Sutcu Imam University. Status unknown at 1 site in Turkey. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-18.
Sponsored by Kahramanmaras Sutcu Imam University · Not applicable, Interventional, and Prevention
A randomized control trial was made to examine the effects of breastfeeding support given by the video-conferencing method in the early postpartum period on anxiety, breastfeeding self-efficiency, and newborn outcomes.
4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.
This study's planned enrollment of 78 is close to the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Kahramanmaras Sutcu Imam University is the lead sponsor of 192 studies on the registry; 40 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Infants;
Mothers;
Exclusion Criteria:
The mothers in the video-conferencing group were counseled via video-conferencing a total of six times (three times a week, at equal intervals) during the first 2 weeks after birth. Each interview was approximately 15-20 minutes. In video-conferencing sessions, the breastfeeding position, the mother's grasping the breast, the baby's latch-on, and sucking duration were observed. Mothers' questions were answered and solutions were offered for breastfeeding problems (sore nipple, engorgement, etc.).
Behavioral: Video-conferencing group
The mothers in the control group were given usual care before discharge and no intervention was made after discharge.
No intervention
Also known as: Control group
The mean postpartum maternal anxiety level (mean ± SD)
The primary outcome of this study was the mean postpartum maternal anxiety level (mean ± SD) of the mothers at 2 weeks and 4 weeks after delivery. Maternal anxiety level was assessed using the Postpartum Specific Anxiety Scale. The scale comprises 51 items and 4 sub-dimensions. It means that those who score 73 and below on the scale have low postpartum anxiety levels, those who score between 74 and 100 have a medium level, and those who score 101 and above have a high level of anxiety.
Time frame: at 2 weeks and 4 weeks after delivery
The mean breastfeeding self-efficacy level
The other main outcome of the study was the mean breastfeeding self-efficacy level (mean ± SD) measured with the Breastfeeding Self-Efficacy Scale Short Form. The scale is likert type and a total score between 14 and 70 is taken from the scale. The higher the score, the higher the breastfeeding self-efficacy.
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Newborn weight (g)
Newborn weight (g) was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Hypoglycemia of the newborn
Hypoglycemia of the newborn was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery.
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Need for phototherapy
The need for phototherapy was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Respiratory morbidity
Respiratory morbidity was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-illness requiring hospitalization
Illness requiring hospitalization was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Food intake other than breast milk
Food intake other than breast milk was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Time frame: at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Neonatal death
Neonatal death was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Time frame: at 2 weeks and 4 weeks after delivery
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kahramanmaras Sutcu Imam University